Dew - why would you think there's a possibility of no interest in CX717 for ADHD? The ADHD trial results last year certainly seemed good enough to warrant BP interest. And why do you think Cortex doing a financing has hurt the credibility of the company? I know of few cases where longs aren't disappointed in a PIPE for a development stage biotech, but that doesn't raise any credibility issues.